Pakistan Drug Firms Note Lower Investment As Regulatory Policy Wavers
This article was originally published in PharmAsia News
Executive Summary
Pakistan's drug makers note investment in their local pharmaceutical industry has declined over the past two years as the government continued to operate without a regulatory chief executive to set policy.